PDCD1 and melanoma: Our working hypothesis is that the melanoma-specific T cells shunted to the lung in the presence of the infection express high levels of inflammation-induced cell-activation blocker PD-1, which upon interacting with PD-L1 constitutively expressed in the lung, render T cell motility paralysis (8).